proline has been researched along with ceronapril in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (11.90) | 18.7374 |
1990's | 34 (80.95) | 18.2507 |
2000's | 3 (7.14) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, BZ; Mendelsohn, FA | 1 |
Feldon, J; Rawlins, JN; Smith, AD; Weiner, I | 1 |
Kaneko, K; Osugi, S; Shimamura, K; Sunano, S; Yamamoto, K | 1 |
Barnes, JM; Barnes, NM; Costall, B; Coughlan, J; Kelly, ME; Naylor, RJ; Tomkins, DM; Williams, TJ | 1 |
Brennan, J; Mantha, S; Stouffer, B; Tsay, HM; Tu, JI; Turabi, N | 1 |
Katsumura, H; Ogawa, N; Ohara, N; Ono, H; Takizawa, M; Yokota, S | 1 |
Grupp, LA | 1 |
Chikugo, T; Morita, N; Ohta, Y; Okamoto, K; Shiokawa, H | 1 |
Barnes, NM; Costall, B; Egli, P; Horovitz, ZP; Ironside, JW; Naylor, RJ; Williams, TJ | 2 |
Barnes, NM; Cheng, CH; Costall, B; Naylor, RJ; Williams, TJ; Wischik, CM | 1 |
DeForrest, JM; Hammerstone, S; Harvey, C; Karanewsky, D; Powell, JR; Scalese, R; Waldron, TL | 1 |
Chikugo, T; Hamada, Y; Morita, N; Ohta, Y; Okamoto, K; Shiokawa, H | 1 |
Konishi, C; Ohara, N; Ono, H; Shukunobe, K; Yokota, S | 1 |
Costall, B; Domeney, AM; Gerrard, PA; Horovitz, ZP; Kelly, ME; Naylor, RJ; Tomkins, DM | 1 |
Hiwada, K; Inoue, Y; Kokubu, T | 1 |
Badia, MC; Cushman, DW; DeForrest, JM; Dejneka, T; Karanewsky, DS; Lee, VG; Loots, MJ; Petrillo, EW | 1 |
Cushman, DW; DeForrest, JM; Fung, WC; Grover, GJ; Harvey, CM; Mitch, SL; Scalese, RJ; Wang, FL | 1 |
Amidon, GL; Friedman, DI | 1 |
Costall, B; Coughlan, J; Horovitz, ZP; Kelly, ME; Naylor, RJ; Tomkins, DM | 1 |
Brittain, HG; Cohen, AI; Ivashkiv, E; Kadin, H | 1 |
Badia, MC; Cushman, DW; DeForrest, JM; Dejneka, T; Karanewsky, DS; Loots, MJ; Perri, MG; Petrillo, EW; Powell, JR | 1 |
Higashimori, K; Katahira, K; Kohara, K; Mikami, H; Moriguchi, A; Morishita, R; Nagano, M; Ogihara, T; Okuda, N; Otsuka, A | 1 |
Higaki, J; Katsuya, T; Mikami, H; Morishita, R; Nakamura, F; Ogihara, T; Rakugi, H; Tomita, N; Yu, H | 1 |
Minck, KO; Raddatz, P; Rippmann, F; Schmitges, CJ | 1 |
Fujishima, M; Ibayashi, S; Nagao, T; Sadoshima, S | 1 |
Ikeda, M; Kishi, K | 1 |
Cutler, NR; Markowitz, J; Mickelson, W; Repetti, S; Sramek, JJ; Sudilovsky, A; Veroff, AE; Wardle, T | 1 |
Fujii, K; Fujishima, M; Ibayashi, S; Ooboshi, H; Sadoshima, S | 1 |
Paulson, OB; Torup, M; Waldemar, G | 1 |
Doi, Y; Kagimoto, M; Kato, K; Kawasaki, K; Koga, S; Sakai, K; Sakaue, A; Sasaki, J; Takada, K; Takii, M | 1 |
Bathala, MS; Chong, S; Dando, SA; Kripalani, KJ; Marino, AM; Morrison, RA | 1 |
Brass, EP; Brennan, JJ; Cutler, NR; Kurtz, NM; Luna, A; Mena, I; Sramek, JJ | 1 |
Chong, S; Irwin, WJ; Marino, AM; Moore, VA; Morrison, RA; Timmins, P; Wasserman, MA | 1 |
Chalas, A; Conway, EL | 1 |
Chikugo, TA; Hamada, Y; Niisato, E; Ohta, Y; Okamoto, K; Otori, T; Suzuki, T | 1 |
Chichibu, S; Chikugo, T; Ohta, Y; Suzuki, T | 1 |
Akhtar, S; Brown, T; Dunnion, DJ; Irwin, WJ; Moore, VA | 1 |
Costall, B; Naylor, RJ | 1 |
Chong, S; Dando, SA; Irwin, WJ; Moore, VA; Morrison, RA; Timmins, P | 1 |
Chong, S; Dando, SA; Irwin, WJ; Lambert, PA; Moore, VA; Morrison, RA; Timmins, P | 1 |
Kinsella, BT; O'Meara, SJ | 1 |
3 trial(s) available for proline and ceronapril
Article | Year |
---|---|
A pilot clinical trial of the angiotensin-converting enzyme inhibitor ceranapril in Alzheimer disease.
Topics: Aged; Alzheimer Disease; Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Organophosphorus Compounds; Pilot Projects; Proline | 1993 |
Hypotensive effects and influence on serum lipids of SQ29,852, a new angiotensin converting enzyme inhibitor, in patients with essential hypertension: a comparison with atenolol.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Apolipoproteins; Arteriosclerosis; Atenolol; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Lipids; Lipoproteins; Male; Middle Aged; Organophosphorus Compounds; Phosphatidylcholine-Sterol O-Acyltransferase; Proline | 1993 |
Effect of the ACE inhibitor ceronapril on cerebral blood flow in hypertensive patients.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cerebrovascular Circulation; Chlorthalidone; Diuretics; Drug Therapy, Combination; Female; Homeostasis; Humans; Hypertension; Male; Middle Aged; Organophosphorus Compounds; Proline; Xenon Radioisotopes | 1996 |
39 other study(ies) available for proline and ceronapril
Article | Year |
---|---|
Effect of acute and chronic administration of ceronapril on angiotensin converting enzyme in plasma, kidney, lung, brain regions and cerebrospinal fluid of rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Autoradiography; Brain; Iodine Radioisotopes; Kidney; Lung; Male; Organophosphorus Compounds; Peptidyl-Dipeptidase A; Proline; Rats; Rats, Sprague-Dawley | 1992 |
A neuroleptic-like effect of ceronapril on latent inhibition.
Topics: Acoustic Stimulation; Animals; Antipsychotic Agents; Conditioning, Operant; Dextroamphetamine; Emotions; Handling, Psychological; Male; Organophosphorus Compounds; Proline; Rats; Rats, Wistar | 1992 |
Effects of chronic treatment with SQ29852 on spontaneous smooth muscle tone and endothelium-dependent relaxation in aorta of stroke-prone spontaneously hypertensive rats.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Captopril; Endothelium, Vascular; Hypertension; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR | 1992 |
Angiotensin-converting enzyme inhibition, angiotensin, and cognition.
Topics: Acetylcholine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Behavior, Animal; Brain; Catecholamines; Cognition; Female; Habituation, Psychophysiologic; Humans; Mice; Organophosphorus Compounds; Potassium; Proline; Rats; Scopolamine | 1992 |
Radioimmunoassay for ceronapril, a new angiotensin-converting enzyme inhibitor, and its application to a pharmacokinetic study in healthy male volunteers.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Proteins; Drug Tolerance; Glutaral; Humans; Iodine Radioisotopes; Male; Organophosphorus Compounds; Proline; Protein Binding; Radioimmunoassay; Reference Standards; Thyroglobulin | 1992 |
Hypotensive effect of a phosphorus-containing novel angiotensin converting enzyme inhibitor, (S)-1-[6-amino-2[[hydroxy(4-phenylbutyl)phosphinyl] oxy]-1-oxohexyl]-L-proline (SQ 29,852) in conscious hypertensive dogs.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Dogs; Enalapril; Female; Hypertension; Organophosphorus Compounds; Proline; Renin | 1992 |
Effects of angiotensin II and an angiotensin converting enzyme inhibitor on alcohol intake in P and NP rats.
Topics: Alcohol Drinking; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Dose-Response Relationship, Drug; Male; Organophosphorus Compounds; Proline; Rats; Renin-Angiotensin System; Species Specificity | 1992 |
Chronic treatment with captopril, SQ29,852, hydralazine and a 33% fish meal diet in malignant stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Captopril; Cerebrovascular Disorders; Fish Products; Hydralazine; Hypertension, Malignant; Life Expectancy; Male; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1991 |
Characterisation of [3H]ceranapril recognition sites in rat and human brain tissue.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Brain; Captopril; Enalapril; Female; Fosinopril; Humans; Kinetics; Lisinopril; Male; Middle Aged; Organophosphorus Compounds; Proline; Rats; Thiorphan | 1991 |
Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cerebellum; Female; Frontal Lobe; Humans; Male; Organophosphorus Compounds; Peptidyl-Dipeptidase A; Proline; Temporal Lobe; Tritium | 1991 |
Ceranapril (SQ 29,852), an orally active inhibitor of angiotensin converting enzyme (ACE).
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dogs; Female; Hypertension; Hypertension, Renovascular; Lung; Macaca fascicularis; Male; Nephrectomy; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Renal Circulation; Species Specificity | 1990 |
Therapy and prevention of hypertension of M-SHRSP.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cerebrovascular Disorders; Diet; Disease Models, Animal; Disease Susceptibility; Fish Flour; Hydralazine; Hypertension, Malignant; Male; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR | 1991 |
Pharmacology of a phosphorus-containing novel angiotensin converting enzyme inhibitor, SQ 29 852 in anesthetized dogs.
Topics: Anesthesia; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Flow Velocity; Captopril; Dogs; Female; Hemodynamics; Infusions, Intravenous; Male; Organophosphorus Compounds; Proline; Vascular Resistance; Vasodilation | 1991 |
Effects of captopril and SQ29,852 on anxiety-related behaviours in rodent and marmoset.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anxiety; Behavior, Animal; Callitrichinae; Captopril; Diazepam; Drug Interactions; Female; Male; Mice; Organophosphorus Compounds; Proline; Rats; Species Specificity; Substance Withdrawal Syndrome | 1990 |
Effect of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, on the activity of angiotensin converting enzyme from human kidney.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Enalaprilat; Humans; Kidney; Kinetics; Organophosphorus Compounds; Peptidyl-Dipeptidase A; Proline; Protease Inhibitors | 1990 |
The ACE inhibitor [3H]SQ29,852 identifies a high affinity recognition site located in the human temporal cortex.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Binding Sites; Cerebral Cortex; Humans; In Vitro Techniques; Iodine Radioisotopes; Kinetics; Male; Middle Aged; Organophosphorus Compounds; Proline; Temporal Lobe | 1990 |
(Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme. 2. Terminal amino acid analogues of (S)-1-[6-amino-2 [[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Chemical Phenomena; Chemistry; Indoles; Male; Organophosphorus Compounds; Proline; Rabbits; Rats; Rats, Inbred Strains; Stereoisomerism; Structure-Activity Relationship | 1990 |
Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Captopril; Chemotherapy, Cancer, Regional Perfusion; Dose-Response Relationship, Drug; Enalapril; Fosinopril; Heart; Hypertension; Lisinopril; Male; Organophosphorus Compounds; Proline; Ramipril; Rats; Time Factors; Tissue Distribution | 1989 |
Intestinal absorption mechanism of dipeptide angiotensin converting enzyme inhibitors of the lysyl-proline type: lisinopril and SQ 29,852.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cephradine; Chromatography, High Pressure Liquid; Enalapril; In Vitro Techniques; Intestinal Absorption; Kinetics; Lisinopril; Organophosphorus Compounds; Proline; Rats; Spectrophotometry, Ultraviolet | 1989 |
The effects of ACE inhibitors captopril and SQ29,852 in rodent tests of cognition.
Topics: Age Factors; Angiotensin-Converting Enzyme Inhibitors; Animals; Behavior, Animal; Captopril; Cognition; Drug Interactions; Habituation, Psychophysiologic; Male; Mice; Organophosphorus Compounds; Proline; Rats; Scopolamine; Time Factors | 1989 |
Body fluid analysis of a phosphonic acid angiotensin-converting enzyme inhibitor using high-performance liquid chromatography and post-column derivatization with o-phthalaldehyde.
Topics: Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; o-Phthalaldehyde; Organophosphorus Compounds; Proline; Spectrometry, Fluorescence | 1989 |
(Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L -proline a novel orally active inhibitor of ACE.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Indicators and Reagents; Lung; Magnetic Resonance Spectroscopy; Male; Optical Rotation; Organophosphorus Compounds; Proline; Rabbits; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1988 |
Differential control of vascular tone and heart rate by different amino acid neurotransmitters in the rostral ventrolateral medulla of the rat.
Topics: Anesthesia; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Heart Rate; Injections; Male; Medulla Oblongata; Microdialysis; Muscle Tonus; Muscle, Smooth, Vascular; Neurotransmitter Agents; Nitroglycerin; Organophosphorus Compounds; Proline; Rats; Rats, Wistar | 1994 |
Differential regulation of brain angiotensin II in genetically hypertensive and normotensive rats after nephrectomy.
Topics: Angiotensin II; Animals; Blood Pressure; Brain Chemistry; Hypertension; Male; Nephrectomy; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Renin-Angiotensin System | 1994 |
Non-peptide renin inhibitors containing 2-(((3-phenylpropyl)phosphoryl)oxy)alkanoic acid moieties as P2-P3 replacements.
Topics: Amino Acid Sequence; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Blood Pressure; Cathepsin D; Female; Humans; Macaca fascicularis; Models, Molecular; Molecular Sequence Data; Organophosphorus Compounds; Pepsin A; Proline; Renin; Stereoisomerism; Structure-Activity Relationship | 1994 |
Inhibition of angiotensin-converting enzyme modulates the autoregulation of regional cerebral blood flow in hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cerebrovascular Circulation; Homeostasis; Hypertension; Male; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR | 1994 |
Chronic effects of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, in experimental hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Enalapril; Hypertension, Renovascular; Male; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR | 1993 |
Angiotensin converting enzyme inhibitors attenuate ischemic brain metabolism in hypertensive rats.
Topics: Adenosine Triphosphate; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Brain; Captopril; Cerebrovascular Circulation; Female; Ischemic Attack, Transient; Lactates; Organophosphorus Compounds; Parietal Lobe; Proline; Pyruvates; Rats; Rats, Inbred SHR; Regional Blood Flow | 1993 |
Ceranapril and cerebral blood flow autoregulation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cerebrovascular Circulation; Homeostasis; Hypertension; Male; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors | 1993 |
Distribution of the dipeptide transporter system along the gastrointestinal tract of rats based on absorption of a stable and specific probe, SQ-29852.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Digestive System; Dipeptides; Dose-Response Relationship, Drug; Male; Organophosphorus Compounds; Proline; Rats; Rats, Sprague-Dawley | 1996 |
Suitability of enalapril as a probe of the dipeptide transporter system: in vitro and in vivo studies.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport; Caco-2 Cells; Cefaclor; Dipeptides; Dogs; Dose-Response Relationship, Drug; Enalapril; Humans; In Vitro Techniques; Intestinal Absorption; Jejunum; Male; Models, Biological; Organophosphorus Compounds; Permeability; Proline; Rats | 1996 |
No evidence for involvement of angiotensin II in spatial learning in water maze in rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Cholinergic Antagonists; Diazepam; GABA Modulators; Imidazoles; Injections, Intraventricular; Losartan; Maze Learning; Memory; Organophosphorus Compounds; Proline; Psychomotor Performance; Rats; Renin; Scopolamine; Tetrazoles | 1996 |
Ocular fundus changes in malignant or precocious stroke-prone spontaneously hypertensive rats after administration of antihypertensive drugs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Calcium Channel Blockers; Cerebrovascular Disorders; Dihydropyridines; Fundus Oculi; Histocytochemistry; Hypertension; Male; Nitrobenzenes; Organophosphorus Compounds; Piperazines; Proline; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1995 |
Electroencephalographic evaluation of the therapeutic efficiency of antihypertensive agents on M-SHRSP.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Calcium Channel Blockers; Dihydropyridines; Electroencephalography; Hypertension, Malignant; Longevity; Male; Nitrobenzenes; Organophosphorus Compounds; Piperazines; Proline; Rats; Rats, Inbred SHR | 1995 |
Interaction of oligonucleotide-conjugates with the dipeptide transporter system in Caco-2 cells.
Topics: Angiotensin-Converting Enzyme Inhibitors; Biological Transport; Caco-2 Cells; Dipeptides; Dose-Response Relationship, Drug; Glyceryl Ethers; Humans; Oligodeoxyribonucleotides; Organophosphorus Compounds; Proline; Thionucleotides; Vitamin E | 1997 |
The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
Topics: Animals; Avoidance Learning; Behavior, Animal; Benzodiazepinones; Darkness; Devazepide; Diazepam; Drug Antagonism; Fenclonine; Indoles; Light; Losartan; Male; Meglumine; Mice; Organophosphorus Compounds; Proline; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Ritanserin; Serotonin Antagonists; Sulfonamides | 1997 |
A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 1: system characterisation.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Caco-2 Cells; Cadherins; Carrier Proteins; Dipeptides; Drug Evaluation, Preclinical; Humans; Kinetics; Lactams; Membrane Transport Proteins; Organophosphorus Compounds; Proline; Substrate Specificity | 2000 |
A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 2: affinities of ACE inhibitors.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; ATP Binding Cassette Transporter, Subfamily B, Member 2; ATP-Binding Cassette Transporters; Caco-2 Cells; Culture Media; Dipeptides; Drug Evaluation, Preclinical; Humans; Models, Biological; Organophosphorus Compounds; Proline; Structure-Activity Relationship | 2000 |
The effect of the farnesyl protein transferase inhibitor SCH66336 on isoprenylation and signalling by the prostacyclin receptor.
Topics: Adrenergic beta-Agonists; Alkyl and Aryl Transferases; Amino Acid Motifs; Animals; Calcium Signaling; Carrier Proteins; Cell Line; Cell Line, Tumor; Cyclic AMP; Dose-Response Relationship, Drug; Endocytosis; Epoprostenol; Farnesyltranstransferase; Heat-Shock Proteins; HSP40 Heat-Shock Proteins; Humans; Iloprost; Isoproterenol; Kidney; Leukemia, Erythroblastic, Acute; Mice; Mutagenesis, Site-Directed; Organophosphorus Compounds; Piperidines; Proline; Propanolamines; Protein Prenylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins p21(ras); Pyridines; Receptors, Adrenergic, beta-2; Receptors, Epoprostenol; Receptors, Thromboxane A2, Prostaglandin H2; Recombinant Fusion Proteins; Signal Transduction; Transfection | 2005 |